Local 12: Cervical cancer on the rise among younger patients
Local 12 featured University of Cincinnati Cancer Center patient Jennifer Wesley and physician-researcher Thomas Herzog, MD, to highlight the importance of screenings as cervical cancer is on the rise among younger patients.
A routine screening at Wesley's gynecologist found she had cervical cancer, and Herzog and the Cancer Center team quickly sprung into action to develop a treatment plan. Herzog said recent research has found cervical cancer is on the rise, and in later stages, among young patients.
"That was shocking because we don't see increases in solid tumors, especially in advanced stages, especially considering that this is a disease for which we can easily screen," Herzog, a Cancer Center member, the Paul and Carolyn Flory Professor in Gynecologic Oncology in the UC College of Medicine and director of UC Health’s Gynecologic Cancer Disease Center, told Local 12. "There's no doubt that COVID has had a negative impact on screening."
Wesley is now cancer free and sharing her story that routine screenings saved her life and could save the lives of others as well.
Watch or read the Local 12 story.
Featured photo at top of cervical cancer metastasis courtesy of National Cancer Institute/Winship Cancer Institute of Emory University. Photo taken by Scott Wilkinson and Adam Marcus.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.